MYOV - Myovant: Relugolix Has Strong Competition October, 14 2020 08:58 AM Myovant Sciences Ltd. Myovant's relugolix has 2 PDUFAs in the next 8 months. However, relugolix has strong competition from AbbVie and other companies. This and other factors make it an avoid. For further details see: Myovant: Relugolix Has Strong Competition